Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme To Build R&D Facility In Beijing

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Genzyme will invest $90 million to build a new R&D center in Beijing's Zhongguancun Life Science Park, the company announced April 22. The 200,000 square-foot center is expected to be operational by 2010 and will have 350 employees working in it

You may also be interested in...



China Life Sciences Parks Look To Differentiate To Attract Big Pharma Business

SHANGHAI - Ten multinational pharmaceutical companies set up R&D centers in China by the end of 2007, most in the booming high-tech parks in Shanghai and Beijing

China Life Sciences Parks Look To Differentiate To Attract Big Pharma Business

SHANGHAI - Ten multinational pharmaceutical companies set up R&D centers in China by the end of 2007, most in the booming high-tech parks in Shanghai and Beijing

Genzyme To Collaborate With China’s Sunway Biotech On Gene Therapy Product

SHANGHAI - Genzyme and Sunway Biotech announced Oct. 25 a collaboration to develop, manufacture and commercialize Ad2/HIF-1a, an experimental gene therapy product, in China

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel